rs116700257

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_004646.4(NPHS1):​c.3562G>A​(p.Ala1188Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000297 in 1,613,560 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0016 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00016 ( 1 hom. )

Consequence

NPHS1
NM_004646.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: -0.105
Variant links:
Genes affected
NPHS1 (HGNC:7908): (NPHS1 adhesion molecule, nephrin) This gene encodes a member of the immunoglobulin family of cell adhesion molecules that functions in the glomerular filtration barrier in the kidney. The gene is primarily expressed in renal tissues, and the protein is a type-1 transmembrane protein found at the slit diaphragm of glomerular podocytes. The slit diaphragm is thought to function as an ultrafilter to exclude albumin and other plasma macromolecules in the formation of urine. Mutations in this gene result in Finnish-type congenital nephrosis 1, characterized by severe proteinuria and loss of the slit diaphragm and foot processes.[provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009373307).
BP6
Variant 19-35830876-C-T is Benign according to our data. Variant chr19-35830876-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 554227.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=1, Benign=2}.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NPHS1NM_004646.4 linkuse as main transcriptc.3562G>A p.Ala1188Thr missense_variant 28/29 ENST00000378910.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NPHS1ENST00000378910.10 linkuse as main transcriptc.3562G>A p.Ala1188Thr missense_variant 28/291 NM_004646.4 P2O60500-1
NPHS1ENST00000353632.6 linkuse as main transcriptc.3442G>A p.Ala1148Thr missense_variant 27/285 A2O60500-2

Frequencies

GnomAD3 genomes
AF:
0.00158
AC:
240
AN:
152210
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00548
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.000390
AC:
98
AN:
251474
Hom.:
0
AF XY:
0.000258
AC XY:
35
AN XY:
135916
show subpopulations
Gnomad AFR exome
AF:
0.00578
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000164
AC:
240
AN:
1461232
Hom.:
1
Cov.:
31
AF XY:
0.000128
AC XY:
93
AN XY:
726998
show subpopulations
Gnomad4 AFR exome
AF:
0.00622
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.000298
GnomAD4 genome
AF:
0.00158
AC:
240
AN:
152328
Hom.:
2
Cov.:
32
AF XY:
0.00154
AC XY:
115
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.00546
Gnomad4 AMR
AF:
0.000589
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.000340
Hom.:
0
Bravo
AF:
0.00176
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000511
AC:
62

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 28, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsJul 10, 2018- -
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 08, 2020This variant is associated with the following publications: (PMID: 28117080) -
Finnish congenital nephrotic syndrome Benign:2
Benign, criteria provided, single submitterclinical testingVasylyeva lab, Texas Tech University Health Sciences CenterOct 06, 2017- -
Benign, criteria provided, single submitterclinical testingCounsylOct 06, 2017- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 07, 2022Variant summary: NPHS1 c.3562G>A (p.Ala1188Thr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00042 in 252492 control chromosomes (gnomAD and Bonomo_2014), predominantly at a frequency of 0.0058 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 2-fold of the estimated maximal expected allele frequency for a pathogenic variant in NPHS1 causing Nephrotic Syndrome, Type 1 phenotype (0.0034), suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.3562G>A has been reported in the literature in at least one heterozygous individual affected with Nephrotic Syndrome, without strong evidence for causality (e.g. Bierzynska_2017) and therefore this report does not provide unequivocal conclusions about association of the variant with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Three laboratories classified the variant as benign (n=1)/likely benign (n=2), and one classified it as VUS. Based on the evidence outlined above, the variant was classified as likely benign. -
NPHS1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 27, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
3.2
DANN
Benign
0.95
DEOGEN2
Benign
0.31
T;.
Eigen
Benign
-0.96
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.015
N
LIST_S2
Benign
0.63
T;T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.0094
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.3
L;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-0.95
N;N
REVEL
Benign
0.049
Sift
Benign
0.058
T;T
Sift4G
Benign
0.17
T;T
Polyphen
0.38
B;.
Vest4
0.24
MVP
0.63
MPC
0.10
ClinPred
0.0033
T
GERP RS
-0.71
Varity_R
0.051
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116700257; hg19: chr19-36321778; COSMIC: COSV105273986; API